Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply
TAIPEI, TAIWAN -
Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the...
Read more: Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations